Latest News
Advanced bowel cancer trial results from FOCUS4: A promising new drug, and treatment breaks
A new drug has shown promise in delaying the time to the disease getting worse in some bowel cancer patients whose cancer has spread elsewhere in the body.
Abiraterone alongside standard therapy helps men with high-risk prostate cancer to live longer
Results from the STAMPEDE trial were presented at the European Society for Medical Oncology Congress 2021
Spotlight on ESMO
The unit had a great presence at EMSO this year with STAMPEDE, FOCUS4 and TRISST all showcasing new results over the weekend
Clarivate Announces Winner of Eugene Garfield Award 2021
Elena Pallari receives award for proposal for innovation in clinical research assessment
ZeNix trial shows lower dose of linezolid can be used for treating highly drug resistant tuberculosis
Results from the ZeNix trial show that the BPaL combination of drugs remains effective against highly drug resistant tuberculosis (TB) with reduced dosage or duration of the linezolid part of the regimen.